IonQ stock initiated with Buy rating at B.Riley on quantum computing growth

IonQ (NYSE:IONQ), a quantum computing company with a $12.1 billion market capitalization, surged 8.6% today, extending its August gains past 80%, following a new Buy rating from B.Riley with a $61 price target. The company is positioned for a third consecutive year of approximately 100% revenue growth, projecting $1 billion in sales and AEBITDA profitability by 2030, underpinned by a $1.6 billion cash balance. Despite trading above its fair value and a 2.4% year-to-date decline in 2025, IonQ recently exceeded Q2 2025 revenue expectations, raised its full-year outlook to $82-100 million, expanded its IP to over 1,000 patents, and is set to launch its fifth-generation product in H2 2025 to capture a significant portion of the estimated $28-86 billion ten-year total addressable market.

Analysis

IonQ (NYSE:IONQ) is experiencing significant positive momentum, evidenced by an 8.6% single-day stock increase and an over 80% gain in August, catalyzed by a new Buy rating initiation from B.Riley with a $61 price target. The company's fundamental growth trajectory is robust, tracking for a third consecutive year of approximately 100% year-over-year revenue gains. This is further substantiated by a recent Q2 2025 revenue beat and an upward revision of its full-year 2025 revenue guidance to $82-100 million. Strategically, IonQ is well-capitalized with a $1.6 billion pro forma cash balance, which analysts believe is sufficient to fund its path to projected AEBITDA profitability by 2030. The company is actively pursuing market share within a large addressable market—estimated at $28-86 billion within ten years—through strategic deals, capability expansion, and the upcoming launch of its fifth-generation product in H2 2025. However, several risk factors temper this bullish outlook. The stock exhibits high volatility with a beta of 2.54, and despite the recent rally, it remains down 2.4% year-to-date in 2025. Furthermore, InvestingPro data suggests the stock is trading above its fair value, and analyst ratings are not uniformly bullish, as Morgan Stanley maintains an Equalweight rating, albeit with a raised price target.

Key Decisions for Investors

• Given the strong revenue growth, raised guidance, and upcoming product catalysts, growth-focused investors could consider the stock as a high-risk, high-reward play on the long-term potential of quantum computing.
• Investors must weigh the aggressive growth narrative against the stock's high volatility (beta of 2.54) and a valuation that is noted to be above fair value, suggesting that any new positions should be sized accordingly to manage risk.
• Closely monitor the execution and market adoption of the fifth-generation product launch in H2 2025 and the company's cash burn rate, as these are critical milestones for validating the path to profitability and justifying the current market capitalization.